概览
Registration has been closed for this forum.
This forum will be conducted in Japanese Language only.
项目委员会
-
Noriko Katori, PHD Division of Drugs
National Institute of Health Sciences, Japan -
Takeshi Hamaura, PHD Head of Pharmaceutical Technology Division
Daiichi Sankyo Co., Ltd., Japan -
Yukio Hiyama, PHD Visiting Researcher
National Institute of Health Sciences, Japan -
Fusashi Ishikawa, PHD, MSC Associate Biopharmaceutics Research Fellow, Formulation R&D Laboratories
Sumitomo Dainippon Pharma Co., Ltd., Japan -
Yoshihiro Matsuda, PHD Senior Scientist (for Quality), Pharmacist
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Sachi Nakane Associate Manager, Research and Development Japan,
Bayer Yakuhin, Ltd., Japan -
Tomoaki Sakamoto, PHD Section Chief, Division of Drugs
National Institute of Health Sciences, Japan -
Satomi Yagi Reviewer, Office of New Drug III
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Mio Yamazaki CMC RA Dept., Regulatory Affairs, Global Medical
GlaxoSmithKline K.K., Japan
